Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

JBS N.V. Issues Q3 2026 Earnings Release via 8-K

JBS N.V. filed a Form 8-K with the SEC on November 9, 2026, disclosing that it issued an earnings release covering results for the quarter ended September 30, 2026.

Manish Choudhary | 09 November 2026

JBS Agrees to Acquire Flora and Canal Rural From J&F

JBS N.V. filed a Form 8-K on November 9, 2026, disclosing that its wholly owned Brazilian subsidiary JBS S.A. entered into two share purchase agreements to acquire Flora Produtos de Higiene e Limpeza S.A. and Canal Rural Produções Ltda. from related party J&F S.A.

Anjali Anand | 09 November 2026

InfuSystem Q3 2026: Net Income Rises to $3.16M

InfuSystem Holdings, Inc. filed its Form 10-Q with the SEC on November 9, 2026, reporting unaudited financial results for the quarterly period ended September 30, 2026, listed on NYSE American under the ticker INFU.

Aditi Sarkar | 09 November 2026

Bain Capital Specialty Finance Q3 2026: NAV Falls to $16.49

Bain Capital Specialty Finance, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the Securities and Exchange Commission on November 9, 2026, reporting a decline in net asset value per share and total net assets compared to year-end 2025.

Nitish Kishor | 09 November 2026

Puma Biotechnology Q3 2026: Net Product Revenue $54.1M

Puma Biotechnology, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 9, 2026, reporting third-quarter net product revenue of $54.1 million and nine-month income from operations of $9.031 million.

Nitish Kishor | 09 November 2026

Bain Capital Specialty Finance Appoints Amrit Kanwal to Board

Bain Capital Specialty Finance, Inc. filed a Current Report on Form 8-K on November 9, 2026, disclosing the appointment of Amrit Kanwal as an independent Class III director, a bylaw amendment expanding the board from eight to nine members, Q3 2026 financial results, and …

Nitish Kishor | 09 November 2026

Amrit Kanwal Files Initial Ownership Report at Bain Capital Specialty Finance

Director Amrit Kanwal filed a Form 3 initial statement of beneficial ownership with the SEC on November 9, 2026, disclosing holdings in Bain Capital Specialty Finance, Inc. as of a triggering event dated November 4, 2026.

Manish Choudhary | 09 November 2026

Baldwin Insurance Group Q3 2026: 98.3M Shares, Go-Private Plan

The Baldwin Insurance Group, Inc. filed its quarterly report on Form 10-Q with the SEC for the period ended September 30, 2026, disclosing financial results, capital structure details, and an ongoing go-private transaction that would delist its Class A common stock from Nasdaq.

Aakashdeep | 09 November 2026

Perspective Therapeutics Q3 2026 Results Filed November 9

Perspective Therapeutics, Inc. filed a current report on Form 8-K on November 9, 2026, disclosing its financial results for the quarter ended September 30, 2026, along with an updated corporate presentation posted the same day.

Aditi Sarkar | 09 November 2026

HF Foods Group Posts Q3 2026 Net Loss of $4.2M

HF Foods Group Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 9, 2026, reporting a net loss attributable to the company of $4,222 thousand for the third quarter.

Shwetambri Chauhan | 09 November 2026
Support

Hi! How can we help you today?

Loading…